Get started

More results...

Filter by Content types
Filter by Geography

Alerts LATEST ALERTS

  • Germany Cabinet approves medical cannabis draft bill on telemedicine ...
  • Michigan - United States New budget law includes heavy tax on adult-use cannabis, industry files suit ...
  • Spain Medical cannabis approved by Council of Ministers ...
  • Brazil Anvisa authorises new cannabis-based product for sale ...
  • Czech Republic Change in government could see stricter measures for cannabis ...
  • Lithuania Court to investigate legality of narcotic substances list ...
  • California - United States Governor signs bill into law that significantly restricts hemp product sales ...
  • Germany Bill to ban online medical cannabis prescriptions notified via TRIS ...
  • Poland Government will not decriminalise cannabis ...
  • Brazil Extension requested to deadline on regulating medical cannabis ...
  • Uruguay MSP and IRCCA announce plans to update cannabis regulations ...
  • Germany BLE rejects Frankfurt's adult-use cannabis pilot project application ...
News analysis

US FDA: You can’t hide health claims for CBD behind other active ingredients

Written by || 31st March 2021 || News analysis | US federal regulation | GeographiesNorth America United States

The US Food and Drug Administration (FDA) has assessed a combined health claim for the first time and denounced the practice of promoting CBD on a product making qualified health claims based on other ingredients
Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
*

I'm already a subscriber

Freddie Dawson

Senior contributing editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the CannIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
*

Sign up to our newsletter

Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.